pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

IN8bio appoints Oxana Polyakova as senior vice president of R&D

Sep 18, 2026·read at STAT ↗Positive

IN8bio announced a new senior vice president for research and development.

Oxana Polyakova joins the company after serving as chief scientific officer at LAVA Therapeutics.

Her background in drug discovery is expected to strengthen IN8bio's pipeline and R&D capabilities.

The hire signals the company's focus on expanding its leadership team in the biotech sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Up and down the ladder: The latest comings and goings”

read at STAT ↗
470 words · retrieved 30m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: Roche expands its Boston footprint with new research centerSTAT
  • 1h agoSTAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and moreSTAT
  • 2h agoWho supports policies for ‘health equity’? It depends on how you’re askingSTAT
  • 6h agoSTAT+: A geriatrician explains why AI for older adults deserves careful scrutinySTAT
  • 6h agoIn Sudan, attacks on hospitals force patients to make dangerous journeysSTAT